Latest news
Loading news…
Kivu Bioscience
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. San Francisco, California, United States Founded 2024 11-50 employees For Profit
Kivu Bioscience is a biotechnology company that focuses on developing next-generation antibody-drug conjugates to target cancer.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 23
- IT spend
- $64K
Company Info
- Founded
- 2024
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 19
- HQ
- San Francisco, California, United States
- Region
- San Francisco Bay Area, West Coast, Western US
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- 2.4
- Trend (30d)
- -0.4
- Trend (90d)
- -2.2
- Last leadership hire
- Mar 3, 2026
Key People at Kivu Bioscience
President & COO
Chief Medical Officer
SVP and Head of Translational Medicine
Chief Scientific Advisor
Chief Business Officer
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Kivu Bioscience
Loading news…
FAQs about Kivu Bioscience
People who checked this page also checked these
Browse the full Acquirezy directory.